BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8420144)

  • 1. Mitochondrial energy crisis in Parkinson's disease.
    Mizuno Y; Ikebe S; Hattori N; Kondo T; Tanaka M; Ozawa T
    Adv Neurol; 1993; 60():282-7. PubMed ID: 8420144
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitochondrial complex I deficiency in Parkinson's disease.
    Schapira AH
    Adv Neurol; 1993; 60():288-91. PubMed ID: 8420145
    [No Abstract]   [Full Text] [Related]  

  • 3. Urodynamic study in the differential diagnosis between multiple system atrophy and Parkinson's disease.
    Stocchi F; Barbato L; Carbone A; Fabbrini G; Ruggieri S; Bonamartini A; Baffigo G; Agnoli A
    Adv Neurol; 1993; 60():434-7. PubMed ID: 8420168
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical aspects of Parkinson's disease.
    Nagatsu T
    Adv Neurol; 1993; 60():165-74. PubMed ID: 8093575
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathogenesis and animal studies of Parkinson's disease.
    Oertel WH; Kupsch A
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):323-32. PubMed ID: 8507901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nigrostriatal system in Parkinson's disease.
    Graybiel AM; Hirsch EC; Agid Y
    Adv Neurol; 1990; 53():17-29. PubMed ID: 1978514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D1 and D2 receptors in Parkinson's disease and striatonigral degeneration determined by PET.
    Shinotoh H; Hirayama K; Tateno Y
    Adv Neurol; 1993; 60():488-93. PubMed ID: 8420176
    [No Abstract]   [Full Text] [Related]  

  • 8. Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness.
    Hornykiewicz O
    Neurodegener Dis; 2008; 5(3-4):114-7. PubMed ID: 18322366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms.
    Hornykiewicz O
    Adv Neurol; 1993; 60():140-7. PubMed ID: 8420131
    [No Abstract]   [Full Text] [Related]  

  • 10. Early and late molecular events occurring following neuronal degeneration in the dopamine system.
    Joh TH; Weiser M
    Adv Neurol; 1993; 60():316-20. PubMed ID: 8093580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal.
    Schapira AH
    Mov Disord; 1994 Mar; 9(2):125-38. PubMed ID: 8196673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Search for the cause of Parkinson's disease].
    Langston JW
    Arch Neurobiol (Madr); 1991; 54(6):264-71. PubMed ID: 1811457
    [No Abstract]   [Full Text] [Related]  

  • 13. Extrastriatal dopamine and Parkinson's disease.
    Parent A; Cossette M
    Adv Neurol; 2001; 86():45-54. PubMed ID: 11554008
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism.
    Chiueh CC; Miyake H; Peng MT
    Adv Neurol; 1993; 60():251-8. PubMed ID: 8380519
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of repetitive and nonrepetitive sequential arm movements in patients with Parkinson's disease.
    Agostino R; Berardelli A; Formica A; Stocchi F; Accornero N; Manfredi M
    Mov Disord; 1994 May; 9(3):311-4. PubMed ID: 8041371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Parkinson disease--a mitochondrial myopathy?].
    Reichmann H; Janetzky B; Klinge M; Riederer P
    Nervenarzt; 1993 Apr; 64(4):215-20. PubMed ID: 8506008
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of the subthalamic nucleus in the pathophysiology of Parkinson's disease.
    Blandini F
    Funct Neurol; 2001; 16(4 Suppl):99-106. PubMed ID: 11996537
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxidative mechanisms in nigral cell death in Parkinson's disease.
    Jenner P
    Mov Disord; 1998; 13 Suppl 1():24-34. PubMed ID: 9613715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity.
    Gash DM; Rutland K; Hudson NL; Sullivan PG; Bing G; Cass WA; Pandya JD; Liu M; Choi DY; Hunter RL; Gerhardt GA; Smith CD; Slevin JT; Prince TS
    Ann Neurol; 2008 Feb; 63(2):184-92. PubMed ID: 18157908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.
    Hodaie M; Neimat JS; Lozano AM
    Neurosurgery; 2007 Jan; 60(1):17-28; discussion 28-30. PubMed ID: 17228250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.